News
Press Releases
.jpg)
-
- 03
- 2022/08
Ms. Cheng Cheung Ling, President of CP Pharmaceutical Group and Chairwoman of Beijing Tide Pharmaceutical, Was Awarded "Top 10 Figures in Pharmaceutical Industry"
On August 3, 2022, the 14th China Health Forum - Top 10 Figures in Pharmaceutical Industry list release ceremony was held. Ms. Cheng Cheung Ling, President of CP Pharmaceutical Group, Vice Chairwoman of the Board of Directors of Sino Biopharm, and Chairwoman of the Board of Directors of Beijing Tide Pharmaceutical Co.View > -
- 29
- 2022/07
Mr. Tse, Eric S Y Becomes the Chief Executive Officer of Sino Biopharm and Will Focus on "Four Strategies"
From July 28, Mr. Tse, Eric S Y will take over the position of Chief Executive Officer of Sino Biopharm. Mr. Li Yi, the former executive director and chief executive officer of Sino Biopharm, will no longer serve in the aforementioned position due to his intention to focus on other business development, and upon his resignation, Mr. Li Yi was appointed as a senior advisor to the company.View > -
- 18
- 2022/07
"Warm Sino Biopharm, Love for Children" Sino Biopharm Held a Corporate Family Day
Family is the harbor for employees to rest and also the backing for enterprise development. In order to further build the "family" culture in Sino Biopharm, Sino Biopharm started the initiative of "Warm Sino Biopharm, Love for Children" in a warm and harmonious atmosphere on July 15. Nearly 200 employees and family members of the Group gathered together to participate in the wonderful parent-child activities and talk about the warm story of "family and enterprise".View > -
- 13
- 2022/07
Sino Biopharm Ranked 2nd in "Top 100 Chinese Chemical and Medical Enterprises in 2021"
The 2022 Misi Conference, hosted by Menet, was held in Huzhou on July 12, and the series of "Top 100 China Pharmaceutical Industry List 2021" were selected from two dimensions: innovation drive and professional promotion power. Among them, Sino Biopharm won the second place in the list of "Top 100 Chinese Chemical and Medical Enterprises in 2021".View > -
- 07
- 2022/07
CP Pharmaceutical Group President Ms. Cheng Cheung Ling Attended a Series of Activities to Celebrate the 25th Anniversary of Hong Kong’s return to China
From June 30 to July 1, Xi Jinping, General Secretary of the Communist Party of China (CPC) Central Committee, President of the State Council and Chairman of the Central Military Commission, came to Hong Kong to attend the conference celebrating the 25th anniversary of Hong Kong's return to the motherland and the inauguration of the sixth government of the Hong Kong Special Administrative Region,View > -
- 17
- 2022/06
Hong Kong CPPCC Members Association Celebrates 16th Anniversary, Ms. Cheng Cheung Ling: CPPCC Members Will Contribute New Strength for Hong Kong to Open a New Chapter
The Hong Kong CPPCC Members Association, chaired by Ms. Cheng Cheung Ling, Vice Chairwoman of the Board of Directors of Sino Biopharm and Chairman of Beijing Tide Pharmaceuticals, held a ceremony to celebrate the 25th anniversary of Hong Kong's return to the motherland and the 16th anniversary of the Hong Kong CPPCC Members Association at the Hong Kong Convention and Exhibition Centre on the evening of June 16.View > -
- 14
- 2022/06
On the List Again! Sino Biopharm Ranked 40th in the Top 50 Global Pharmaceutical Companies
On June 10, Pharm Exec (Pharmaceutical Executive Magazine in the US) announced the Top 50 Global Pharmaceutical Companies in 2022, and Sino Biopharm entered the list for the fourth consecutive year, with a steady rise in ranking to No. 40.View > -
- 31
- 2022/05
Sino Biopharm Released 2021 ESG Report and Focus on Strengthening the Construction of"Responsible Sino Biopharm"
On May 31, the Sino Biopharm 2021 Annual Environmental, Social and Governance (ESG) Report was released.As an innovation-led biopharmaceutical company, in 2021, Sino Biopharm will take "maintaining the dignity of life and improving the quality of life" as its development vision, adhere to the concept of "technology creates value" and the values of "benefit the country, benefit the people and benefit the enterprise".View > -
- 31
- 2022/05
CTTQ of Sino Biopharm Donates Epidemic Prevention Materials to Jiangsu Retirement Home
On May 30, CTTQ Pharmaceutical Group donated 2,000 sets of epidemic-proof protective suits to Jiangsu Retirement Home to help the regular prevention and control of the epidemic in Nanjing, and to provide material support for medical personnel, community workers and volunteers who are on the front line of fighting against the epidemic.View > -
- 16
- 2022/05
Sino Biopharm Was Named to Top 50 Global Pharmaceutical Companies in 2022
On May 15, Medaverse (Pharma Universe) released its 2022 Top 50 Global Pharmaceutical Companies list, which ranks pharmaceutical companies based on their sales revenue of prescription drug in 2021, with six Chinese companies on the list, including Hong Kong-listed Sino Biopharm Limited (HK.01177) at No. 40 and affiliates Sinovac Life Sciences, whose parent company of Nasdaq-listed Sinovac Biotech Ltd. was ranked 17th.View >